Acadia Healthcare Company Inc.

Operating internationally, Acadia Healthcare Co Inc develops and operates a network of behavioural health facilities. The company provides chemical dependency and psychiatric services within the US, the UK, and Puerto Rico. As of September 2020, Acadia Healthcare operated approximately 18,300 beds within 582 behavioural healthcare facilities. Headquartered in Franklin, Tennessee, the company was founded in 2005. Available on the NASDAQ GS stock market, Acadia Healthcare uses the ACHC ticker. As of November 2020, this stock provided a 34.42% one-year return. During the same period, the ACHC share price ranged from a 52-week low of $11.09 in March 2020 to a 52-week high of $44.75, which was achieved in both October and November 2020. In November 2020, the stock was trading at $43.18. The company services patients in a range of settings, including specialty treatment facilities, inpatient psychiatric hospitals, residential treatment centres, therapeutic school-based programs, and outpatient clinics. Acadia Healthcare aims to collaborate with physicians, employees, and all strategic alliances to provide top-tier service to patients. In addition to behavioural health disorders and psychiatric disorders, the company is also equipped to treat patients suffering from eating disorders, PTSD and trauma, memory disorders, developmental disorders, dual diagnosis, and substance abuse. Add ACHC stock to your eToro portfolio to increase the diversity of your holdings.